Antiretroviral Therapy 2016-2017: The Continuing Need for Individualized Therapy to Optimize Outcomes Among Diverse HIV Patients - Home Study

ACPE UAN #:  0233-9999-16-071-H02-P

Release Date:  January 9, 2017

Expiration Date:  December 22, 2017

Activity Type:  Knowledge-based  

Credit Hours:  1.0 contact hours (0.1 CEU)

Activity Fee:  There is no fee to participate in this home study activity. 

Target Audience

This home study activity has been designed to meet the educational needs of pharmacists in managed care settings.

Activity Overview:

Clinicians who prescribe antiretroviral therapy for HIV infection are faced with complex decisions that involve the evaluation of comorbidities, patient preferences and disposition (e.g., evaluation of adherence), concomitant medications, childbearing potential, and other key factors. To address these diverse needs, US practice guidelines classify nine regimens as ‘recommended’ options for HIV therapy, including seven regimens based on an integrase inhibitor and two based on a boosted protease inhibitor. While all of these regimens are safe and effective, they differ in other important characteristics.

During this home study, a clinical pharmacist and managed care pharmacist will use didactic information and illustrative cases to explore how formularies can be better managed to ensure delivery of optimal care for diverse patient populations.

Learning Objectives 

At the completion of this activity, participants should be able to:

  1.  Review the evidence and data regarding the safety and efficacy of current HIV treatment options.
  2.  Describe strategies to provide better treatment to diverse patient populations, such as Medicaid, Medicare Part D, and commercial patients.
  3. Discuss best practices for making better informed formulary and coverage decisions regarding antiretroviral regimens.

Schedule of Educational Activity

  • Clinical Perspective on Treating Diverse HIV Patient Populations -  Danielle F. Ciuffetelli, PharmD
  • Managed Care Perspective on Treating Diverse HIV Patient Populations - Elly Fatehi, PharmD, BCPS

CPE Requirements:   

Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live webinar activities on October 20 and December 6, 2016.  CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor.  Please allow 72 hours for processing and posting in your NABP account.

To receive credit for an online activity you must:

  • Review the full content of the activity.
  • Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
  • Complete a specific activity evaluation.

System Technical Requirements/Viewing Requirements: System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities you should have a basic comfort level using a computer and navigating web sites.  View the minimum technical and system requirements for continuing education online learning activities.

As an ACPE-accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of CPE activities. It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias.

The activity is co-provided by the Academy of Managed Care Pharmacy and Clinical Care Options.

 

Statement of Commercial Support

This educational activity is supported by an unrestricted education grant from Janssen Therapeutics.

Moderator:
Puneet Singh, PharmD
Education Program Manager
Academy of Managed Care Pharmacy
Alexandria, Virginia

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE UAN #0233-9999-16-071-H02-P 1 Contact Hour October 20, 2016 - October 20, 2019